Literature DB >> 16481613

Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice.

Fannie Huang1, Jian Shan, Steven Reiken, Xander H T Wehrens, Andrew R Marks.   

Abstract

The ryanodine receptor (RyR)/calcium-release channel on the sarcoplasmic reticulum mediates intracellular calcium release required for striated muscle contraction. RyR2, the predominant isoform in cardiac myocytes, comprises a macromolecular complex that includes calstabin2 (FKBP12.6). Calstabin2, an 11.8-kDa cis-trans peptidyl-prolyl isomerase (apparent molecular mass 12.6 kDa), stabilizes the closed state of the RyR2 channel, but the mechanism by which it achieves this regulation is not fully understood. Protein kinase A (PKA) phosphorylation of RyR2 decreases the affinity of calstabin2 for the RyR2 channel complex. In the present study we identified key aspartic acid residues on calstabin2 that are involved in binding to RyR2 and likely play a role in PKA phosphorylation-induced dissociation of calstabin2 from RyR2. We show that a mutant calstabin2 in which a key negatively charged residue (Asp-37) has been neutralized binds to a mutant RyR2 channel that mimics constitutively PKA-phosphorylated RyR2 (RyR2-S2808D). Furthermore, using wild-type and genetically altered murine models of heart failure induced by myocardial infarction, we show that manipulating the stoichiometry between calstabin2 and RyR2 can restore normal cardiac function in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16481613      PMCID: PMC1413925          DOI: 10.1073/pnas.0511282103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  FKBP12 binding modulates ryanodine receptor channel gating.

Authors:  M Gaburjakova; J Gaburjakova; S Reiken; F Huang; S O Marx; N Rosemblit; A R Marks
Journal:  J Biol Chem       Date:  2001-03-01       Impact factor: 5.157

2.  Structure of FKBP12.6 in complex with rapamycin.

Authors:  C C Deivanayagam; M Carson; A Thotakura; S V Narayana; R S Chodavarapu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-03

Review 3.  Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers.

Authors:  Andrew R Marks; Steven O Marx; Steven Reiken
Journal:  Trends Cardiovasc Med       Date:  2002-05       Impact factor: 6.677

4.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure.

Authors:  Masateru Kohno; Masafumi Yano; Shigeki Kobayashi; Masahiro Doi; Tetsuro Oda; Takahiro Tokuhisa; Shinichi Okuda; Tomoko Ohkusa; Michihiro Kohno; Masunori Matsuzaki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11-14       Impact factor: 4.733

6.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.

Authors:  H E Kim; S S Dalal; E Young; M J Legato; M L Weisfeldt; J D'Armiento
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor).

Authors:  Haruko Masumiya; Ruiwu Wang; Jing Zhang; Bailong Xiao; S R Wayne Chen
Journal:  J Biol Chem       Date:  2002-11-22       Impact factor: 5.157

8.  Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein.

Authors:  A B Brillantes; K Ondrias; A Scott; E Kobrinsky; E Ondriasová; M C Moschella; T Jayaraman; M Landers; B E Ehrlich; A R Marks
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

9.  PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure.

Authors:  Steven Reiken; Alain Lacampagne; Hua Zhou; Aftab Kherani; Stephan E Lehnart; Chris Ward; Fannie Huang; Marta Gaburjakova; Jana Gaburjakova; Nora Rosemblit; Michelle S Warren; Kun-Lun He; Geng-Hua Yi; Jie Wang; Daniel Burkhoff; Guy Vassort; Andrew R Marks
Journal:  J Cell Biol       Date:  2003-03-10       Impact factor: 10.539

10.  FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Fannie Huang; John A Vest; Steven R Reiken; Peter J Mohler; Jie Sun; Silvia Guatimosim; Long Sheng Song; Nora Rosemblit; Jeanine M D'Armiento; Carlo Napolitano; Mirella Memmi; Silvia G Priori; W J Lederer; Andrew R Marks
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

View more
  30 in total

1.  Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice.

Authors:  Jian Shan; Matthew J Betzenhauser; Alexander Kushnir; Steven Reiken; Albano C Meli; Anetta Wronska; Miroslav Dura; Bi-Xing Chen; Andrew R Marks
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 2.  The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?

Authors:  Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

3.  Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes.

Authors:  Joon Lee; Mark A Stagg; Satsuki Fukushima; Gopal K R Soppa; Urszula Siedlecka; Samuel J Youssef; Ken Suzuki; Magdi H Yacoub; Cesare M N Terracciano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 4.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

Review 5.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

6.  Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.

Authors:  Yan-Ting Zhao; Yun-Bo Guo; Lei Gu; Xue-Xin Fan; Hua-Qian Yang; Zheng Chen; Peng Zhou; Qi Yuan; Guang-Ju Ji; Shi-Qiang Wang
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

7.  Total internal reflectance fluorescence imaging of genetically engineered ryanodine receptor-targeted Ca2+ probes in rat ventricular myocytes.

Authors:  Sara Pahlavan; Marin Morad
Journal:  Cell Calcium       Date:  2017-07-19       Impact factor: 6.817

8.  Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Jian Shan; Wenjun Xie; Matthew Betzenhauser; Steven Reiken; Bi-Xing Chen; Anetta Wronska; Andrew R Marks
Journal:  Circ Res       Date:  2012-07-24       Impact factor: 17.367

9.  A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium.

Authors:  Albano C Meli; Marwan M Refaat; Miroslav Dura; Steven Reiken; Anetta Wronska; Julianne Wojciak; Joan Carroll; Melvin M Scheinman; Andrew R Marks
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

Review 10.  Calcium cycling proteins and heart failure: mechanisms and therapeutics.

Authors:  Andrew R Marks
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.